Centessa Pharmaceuticals (CNTA) Debt to Equity (2022 - 2025)
Historic Debt to Equity for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to $0.36.
- Centessa Pharmaceuticals' Debt to Equity rose 14010.19% to $0.36 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.36, marking a year-over-year increase of 14010.19%. This contributed to the annual value of $0.27 for FY2024, which is 1533.22% down from last year.
- As of Q3 2025, Centessa Pharmaceuticals' Debt to Equity stood at $0.36, which was up 14010.19% from $0.32 recorded in Q2 2025.
- Centessa Pharmaceuticals' Debt to Equity's 5-year high stood at $0.36 during Q3 2025, with a 5-year trough of $0.15 in Q3 2024.
- Its 4-year average for Debt to Equity is $0.26, with a median of $0.27 in 2024.
- As far as peak fluctuations go, Centessa Pharmaceuticals' Debt to Equity crashed by 4683.85% in 2024, and later skyrocketed by 14010.19% in 2025.
- Quarter analysis of 4 years shows Centessa Pharmaceuticals' Debt to Equity stood at $0.21 in 2022, then soared by 54.33% to $0.32 in 2023, then fell by 15.33% to $0.27 in 2024, then soared by 34.22% to $0.36 in 2025.
- Its Debt to Equity was $0.36 in Q3 2025, compared to $0.32 in Q2 2025 and $0.28 in Q1 2025.